Wells Fargo maintained an Outperform rating on InterMune Inc. (NASDAQ:ITMN) and raise its price target to $41-$43 (from $18-$20). The change follows phase 3 study results for Esbriet in idiopathic pulmonary fibrosis (IPF). InterMune Inc (NASDAQ:ITMN) stock opened at $35.69 in last session, and closed at $37.80, while the day range of ITMN stock is $30.20-$38.73.The stock showed a positive weekly performance of 170.77%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)’s shares climbed 2.78% to $1.11. Peter Suzdak, PhD, the Company’s Chief Executive Officer, presented a company update at the 16th Annual BIO CEO & Investor Conference being held in New York City, NY on February 10, 2014 at 2:30pm EST. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock opened at $1.12, in last session and closed at $1.29, by gained 16.22%.The 52 week range was $0.28-$1.85.Company’s market capitalization is $60.27 million.
ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) has been working on its lead product ICT-107 for some time now. The company has however found that the Phase 2 trials for it has failed to meet the primary endpoint itself. The country is now in quick talks with FDA on the future scope of trails in Phase 3. ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) stock gained 14.05% and finished the last session at $1.38. The EPS of the stock remained -0.16.Company’s market capitalization is $78.79 million.
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to therapy and manage side effects arising from cancer treatment, announced that the Company received notice from the NASDAQ Listing Qualifications Staff that it has regained compliance with the minimum $1.00 bid price per share requirement. The previously disclosed NASDAQ delisting matter related to the Company’s bid price compliance is now closed. DARA Biosciences Inc (NASDAQ:DARA) stock opened the session at $3.34, and closed the session at $3.09. The 52 week range of the DARA stock remained $2.25-$5.60 and the day range was $3.04-$3.55.